Velarion Records
Free. Unsubscribe any time.

ACADIA PHARMACEUTICALS INC (ACAD)

ACADIA PHARMACEUTICALS INC filed 27 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 5 reporting owners, covering 35 transactions and 151,813 shares. None carries the SEC's AFF10B5ONE flag; all 27 name a plan in a footnote. 8 results prints are on file in the same window.

What stands out

Trades in ACADIA PHARMACEUTICALS INC 35

Adoption dates in ACADIA PHARMACEUTICALS INC 4

Results prints in ACADIA PHARMACEUTICALS INC 8

Trades before a print in ACADIA PHARMACEUTICALS INC 8

Interval to ACADIA PHARMACEUTICALS INC’s next reported results date

How the interval and sources are counted →

Adoption dates ACADIA PHARMACEUTICALS INC states

Filing text: “10b5-1 trading plan adopted by the Reporting Person on May 30, 2024”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.